These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35113366)

  • 41. Cost-Effectiveness of Repository Corticotropin Injection for the Treatment of Acute Exacerbations in Multiple Sclerosis.
    Hunter SF; Bindra J; Chopra I; Niewoehner J; Panaccio MP; Wan GJ
    Clinicoecon Outcomes Res; 2021; 13():883-892. PubMed ID: 34675568
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Repository corticotropin injection improves quality metrics in an observational study of multiple sclerosis relapse.
    Kaplan J; Miller T; Baker M; Due B; Zhao E
    Neurodegener Dis Manag; 2021 Dec; 11(6):469-476. PubMed ID: 34860120
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of repository corticotrophin injection therapy for pulmonary sarcoidosis: a Delphi study.
    Rahaghi FF; Sweiss NJ; Saketkoo LA; Scholand MB; Barney JB; Gerke AK; Lower EE; Mirsaeidi M; O'Hare L; Rumbak MJ; Samavati L; Baughman RP
    Eur Respir Rev; 2020 Mar; 29(155):. PubMed ID: 32198219
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Publication bias, Open-Labeled Trials and Sky Rocketing Costs- Past, Present and Future of Repository Corticotropin Injection?
    Lobo-Chan AM; MacIntosh P; Bhat P
    Ocul Immunol Inflamm; 2022 Aug; 30(6):1505-1507. PubMed ID: 34242098
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Repository corticotropin injection as adjunctive therapy in patients with rheumatoid arthritis who have failed previous therapies with at least three different modes of action.
    Gillis T; Crane M; Hinkle C; Wei N
    Open Access Rheumatol; 2017; 9():131-138. PubMed ID: 28790870
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of Repository Corticotropin Injection on Medication Use in Patients With Rheumatologic Conditions: A Claims Data Study.
    Myung G; Nelson WW; McMahon MA
    J Pharm Technol; 2017 Aug; 33(4):151-155. PubMed ID: 34861677
    [No Abstract]   [Full Text] [Related]  

  • 47. Current treatment of sarcoidosis.
    Sellarés J; Francesqui J; Llabres M; Hernandez-Gonzalez F; Baughman RP
    Curr Opin Pulm Med; 2020 Sep; 26(5):591-597. PubMed ID: 32701680
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and tolerability of repository corticotropin injection in patients with persistently active SLE: results of a phase 4, randomised, controlled pilot study.
    Furie R; Mitrane M; Zhao E; Das M; Li D; Becker PM
    Lupus Sci Med; 2016; 3(1):e000180. PubMed ID: 27933199
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of Noninfectious Retinal Vasculitis Using Subcutaneous Repository Corticotropin Injection.
    Anesi SD; Chang PY; Maleki A; Stephenson A; Montieth A; Filipowicz A; Syeda S; Asgari S; Walsh M; Metzinger JL; Foster CS
    J Ophthalmic Vis Res; 2021; 16(2):219-233. PubMed ID: 34055260
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and safety of repository corticotropin injection for refractory cutaneous dermatomyositis: a prospective, open-label study.
    Fernandez AP; Gallop J; Polly S; Khanna U
    Rheumatology (Oxford); 2023 Nov; ():. PubMed ID: 37941470
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Repository corticotrophin injection exerts direct acute effects on human B cell gene expression distinct from the actions of glucocorticoids.
    Benko AL; McAloose CA; Becker PM; Wright D; Sunyer T; Kawasawa YI; Olsen NJ; Kovacs WJ
    Clin Exp Immunol; 2018 Apr; 192(1):68-81. PubMed ID: 29205315
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of Subcutaneous Repository Corticotropin Gel Injection on Regulatory T Cell Population in Noninfectious Retinal Vasculitis.
    Anesi SD; Chang PY; Maleki A; Manhapra A; Look-Why S; Asgari S; Walsh M; Drenen K; Foster CS
    Ocul Immunol Inflamm; 2023 Apr; 31(3):556-565. PubMed ID: 35258389
    [TBL] [Abstract][Full Text] [Related]  

  • 53. H.P. Acthar Gel (repository corticotropin injection) treatment of patients with multiple sclerosis and diabetes.
    Kutz C
    Ther Adv Chronic Dis; 2016 Jul; 7(4):190-7. PubMed ID: 27433309
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Individual pituitary neuropeptides do not recapitulate the effects of repository corticotropin (Acthar®) on human B cells in vitro.
    Benko AL; Wright AD; Sunyer T; Olsen NJ; Kovacs WJ
    J Neuroimmunol; 2021 Apr; 353():577522. PubMed ID: 33601128
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Medical resource utilization in dermatomyositis/polymyositis patients treated with repository corticotropin injection, intravenous immunoglobulin, and/or rituximab.
    Knight T; Bond TC; Popelar B; Wang L; Niewoehner JW; Anastassopoulos K; Philbin M
    Clinicoecon Outcomes Res; 2017; 9():271-279. PubMed ID: 28553129
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical experience with repository corticotropin injection in patients with multiple sclerosis experiencing mood changes with intravenous methylprednisolone: a case series.
    Murray S; Woo A
    Ther Adv Neurol Disord; 2016 May; 9(3):189-97. PubMed ID: 27134674
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of Steroidogenic Exposure Following the Administration of Repository Corticotropin Injection With a Synthetic ACTH
    Wang X; Pham L; Poola N; Brooks LR; Due B
    Clin Pharmacol Drug Dev; 2021 Jul; 10(7):777-788. PubMed ID: 33369276
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of third-line therapies in advanced sarcoidosis.
    Lower EE; Sturdivant M; Grate L; Baughman RP
    Clin Exp Rheumatol; 2020; 38(5):834-840. PubMed ID: 31820728
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost per response analysis of repository corticotropin injection
    Wan GJ; Chopra I; Niewoehner J; Hunter SF
    Drugs Context; 2020; 9():. PubMed ID: 33408750
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacotherapeutic management of pulmonary sarcoidosis.
    Fazzi P
    Am J Respir Med; 2003; 2(4):311-20. PubMed ID: 14719997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.